PodParley PodParley
PodParley
Novo Nordisk (Ozempic)

EPISODE · Jan 22, 2024 · 3H 44M

Novo Nordisk (Ozempic)

from Acquired · host Ben Gilbert and David Rosenthal

Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about Novo Nordisk before diving in, our first thought was, “wow, seems like these new diabetes and obesity drugs mean serious trouble for big insulin companies.”And then… we realized that Novo Nordisk IS the big insulin company. And in a story befitting of Steve Jobs and Apple, they’d just disrupted themselves with the drug equivalent of an iPhone moment. Once we dug further, we quickly realized this company has it all: an incredible 100+ year history filled with Nobel Prizes, bitter personal rivalries, board room dramas, a generation-defining silicon valley innovation, lone voices persevering against all odds — and oh yeah, the world’s largest charitable foundation at its helm. Tune in for one incredible story!Sponsors:Sentry: https://bit.ly/acquiredsentryWorkOS: https://bit.ly/workos25Anthropic: https://bit.ly/acquiredclaude25Statsig: https://bit.ly/acquiredstatsig26More Acquired!Get email updates with hints on next episode and follow-ups from recent episodesJoin the SlackSubscribe to ACQ2Merch Store!© Copyright 2015-2026 ACQ, LLCLinks:Chart: US Healthcare Spend by CategoryChart: US Distribution and Reimbursement System (for pharmaceutical drugs)Chart: Insulin Supply ChainYouTube Talk: What People Get Wrong about the Finances of the Drug IndustryAlex Telford: The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about itOut-of-Pocket Health: Obesity DrugsOut-of-Pocket Health: US Healthcare System ProblemsAll episode sourcesCarve Outs:Noxgear Tracer 2 running vestDrops of GodWool by Hugh HoweyMere Mortals at San Francisco BalletBlackberry‍Note: Acquired hosts and guests may hold assets discussed in this episode. This podcast is not investment advice, and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any financial transactions.

NOW PLAYING

Novo Nordisk (Ozempic)

0:00 3:44:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Amex Global Business Travel: The World’s First AI Take Private with Long Lake CEO Alexander Taubman

May 11, 2026 ·22m

184. The 5 Stages of Starting an Education Business

May 6, 2026 ·13m

Baseten CEO Tuhin Srivastava on the AI Inference Crunch, Custom Models, and Building the Inference Cloud

May 1, 2026 ·42m

183. Centering Educator Wellbeing with Monika Robinson of Reparations Ed

Apr 29, 2026 ·36m

SAP: Bringing the ‘Operating System’ of a Company into the AI Era with CTO Philipp Herzig

Apr 23, 2026 ·45m

182. From Classroom to Congress with Will Staton

Apr 22, 2026 ·29m

Similar Podcasts

The Acquired Taste Podcast Whitney Diggs and Jadea Jackson Amazing things arise when two friends can come together to create a safe space to have deep conversations, laugh, and enjoy each other’s company through their unique storytelling. Join Whitney and Jadea in their new and exciting podcast, Acquired Taste, as they cover a wide range of topics including pop culture, personal experiences, and thought-provoking discussions. With their unique perspectives and hilarious banter, you will not want to miss out on the chance to connect through the power of audio. Join us every fourth Sunday for your monthly dose of an Acquired Taste! ACQ2 by Acquired Ben Gilbert and David Rosenthal ACQ2 is Ben and David's conversations with experts on topics related to Acquired. Acquired the stories of great companies — and ACQ2 dives deeper into the lessons we can learn from them, often with the protagonists themselves. Educator Forever Lily Jones, Teacher Advocate There’s a lot that needs to change in education. But there are inspiring movements going on too! At Educator Forever, we believe teachers need to be at the forefront of education reform and be empowered to create career pathways that work for them. Do you ever think about leaving the classroom but have absolutely no idea what else you could do? You may not realize it yet, but you have acquired highly valuable skills throughout your teaching journey, and there is unlimited potential for you to use them. Tune in each week to hear about career opportunities that will help you achieve the income, impact, and freedom you’ve always dreamed of. The best part? You can do all of this without having to leave the world of education entirely. In addition to showing you the many ways you can expand your impact beyond the classroom, we’ll introduce you to inspiring leaders in education. Want to learn about new research? Looking to get familiar with innovative approaches to teaching and learning? No Priors: Artificial Intelligence | Technology | Startups Conviction At this moment of inflection in technology, co-hosts Elad Gil and Sarah Guo talk to the world's leading AI engineers, researchers and founders about the biggest questions: How far away is AGI? What markets are at risk for disruption? How will commerce, culture, and society change? What’s happening in state-of-the-art in research? “No Priors” is your guide to the AI revolution. Email feedback to [email protected] Guo is a startup investor and the founder of Conviction, an investment firm purpose-built to serve intelligent software, or "Software 3.0" companies. She spent nearly a decade incubating and investing at venture firm Greylock Partners.Elad Gil is a serial entrepreneur and a startup investor. He was co-founder of Color Health, Mixer Labs (which was acquired by Twitter). He has invested in over 40 companies now worth $1B or more each, and is also author of the High
URL copied to clipboard!